"Somos una entidad del Ministerio de Salud, dedicada a la investigación, docencia, normatividad y atención especializada de enfermedades que afectan al sistema nervioso central (cerebro y columna vertebral)"

During the past decade, Cysticercosis Unit, Instituto Nacional de Ciencias Neurologicas conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Cysticercosis Unit, Instituto Nacional de Ciencias Neurologicas" are "Neurocysticercosis" (2 trials). Many other conditions were trialed in "Cysticercosis Unit, Instituto Nacional de Ciencias Neurologicas" in a lesser frequency.

Most popular intervention types in "Cysticercosis Unit, Instituto Nacional de Ciencias Neurologicas" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Acetazolamide" (1 trials), "Albendazole and praziquantel" (1 trials), "Albendazole and praziquantel placebo" (1 trials) and "Dexamethasone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cysticercosis Unit, Instituto Nacional de Ciencias Neurologicas" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Cysticercosis Unit, Instituto Nacional de Ciencias Neurologicas". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Cysticercosis Unit, Instituto Nacional de Ciencias Neurologicas, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Cysticercosis Unit, Instituto Nacional de Ciencias Neurologicas, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".